N-terminus of flagellin enhances vaccine efficacy against Actinobacillus pleuropneumoniae
Open Access
- 16 July 2022
- journal article
- research article
- Published by Springer Nature in BMC Veterinary Research
- Vol. 18 (1) , 1-10
Abstract
Background: Flagellin elicits potent immune response and may serve as a vaccine adjuvant. We previously reported that the N-terminus of flagellin (residues 1–99, nFliC) is sufficient for vaccine efficacy enhancement against Pasteurella multocida challenge in chickens. In this study, we futher tested the adjuvancy of nFliC in a subunit vaccine against the pig pathogen Actinobacillus pleuropneumoniae in a mice model. For vaccine formulation, the antigen ApxIIPF (the pore-forming region of the exotoxin ApxII) was combined with nFliC, either through genetic fusion or simple admixture. Results: Immune analysis showed that nFliC, introduced through genetic fusion or admixture, enhanced both humoral (antibody levels) and cellular (T cell response and cytokine production) immunity. In a challenge test, nFliC increased vaccine protective efficacy to 60–80%, vs. 20% for the antigen-only group. Further analysis showed that, even without a supplemental adjuvant such as mineral salt or oil emulsion, genetically linked nFliC still provided significant immune enhancement. Conclusions: We conclude that nFliC is a versatile and potent adjuvant for vaccine formulation.Keywords
This publication has 34 references indexed in Scilit:
- Structural Basis of TLR5-Flagellin Recognition and SignalingScience, 2012
- An immunosorbent assay based on the recombinant ApxIa, ApxIIa, and ApxIIIa toxins ofActinobacillus pleuropneumoniaeand its application to field seraJournal of Veterinary Diagnostic Investigation, 2011
- Malaria Vaccine Development: Are Bacterial Flagellin Fusion Proteins the Bridge between Mouse and Humans?Journal of Parasitology Research, 2011
- New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellinVaccine, 2008
- Putative identification of an amphipathic α-helical sequence in hemolysin of Escherichia coli (HlyA) involved in transmembrane pore formationBiological Chemistry, 2008
- Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunityVaccine, 2007
- On the horizon: a blood test for prionsTrends in Microbiology, 2006
- Variation in bacterial flagellins: from sequence to structureTrends in Microbiology, 2006
- Evasion of Toll-like receptor 5 by flagellated bacteriaProceedings of the National Academy of Sciences, 2005
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001